Article
Pharmacogenomics of beta2-agonist: key focus on signaling pathways.
Pharmacogenomics - 1 Sept 2006
Bhatnagar Pallav, Guleria Randeep, Kukreti Ritushree
Abstract excerpt
Asthma is one of the most common respiratory diseases, where inhalation and exhalation are obstructed due to narrowing of the airways by broncho-constriction or by inflammation. Among all the available anti-asthma therapies, beta2-agonists are the most effective bronchodilators available, and giv...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
